VACS component | Score | Frequency N (%) | Impaired global NCI N (%) | p value |
---|---|---|---|---|
Age (years) | 0.03 | |||
< 50 | 0 | 81 (83.5) | 54 (66.7) | |
50–64 | 12 | 16 (16.5) | 15 (93.8) | |
> 64 | 27 | 00 (00.0) | 00 (00.0) | |
CD4 (cells/mm3) | 0.08 | |||
> 499 | 0 | 41 (42.3) | 26 (63.4) | |
200–499 | 6 | 47 (48.4) | 34 (72.3) | |
100–199 | 10 | 09 (09.3) | 09 (100.0) | |
50–99 | 28 | 00 (00.0) | 00 (00.0) | |
< 50 | 29 | 00 (00.0) | 00 (00.0) | |
Hemoglobin (g/dL) | 0.00 | |||
> 13.9 | 0 | 31 (31.9) | 13 (42.0) | |
12–13.9 | 10 | 27 (26.8) | 20 (74.1) | |
10–11.9 | 22 | 24 (25.7) | 21 (87.5) | |
< 10 | 38 | 15 (15.6) | 15 (100.0) | |
FIB-4a | 0.06 | |||
< 1.45 | 0 | 72 (74.2) | 47 (65.3) | |
1.45–3.25 | 6 | 18 (18.6) | 15 (83.3) | |
> 3.25 | 25 | 07 (07.2) | 06 (85.7) | |
Egfr (mL/min) | 1.00 | |||
> 59.9 | 0 | 96 (99.0) | 68 (70.8) | |
45–59.9 | 6 | 01 (00.0) | 01 (100.0) | |
30–44.9 | 8 | 00 (00.0) | 00 (00.0) | |
< 30 | 26 | 00 (00.0) | 00 (00.0) | |
Hepatitis C Co-infection | 5 | 00 (00.0) |